Zinc finger technologies are composed of a DNA-binding domain, which binds with precision to any sequence of DNA, and various functional domains (such as nucleases and transcription factors) based on therapeutic need. Due to their compact size, ZF technologies are highly vector compatible. Partnering ZF technologies with delivery vectors allows for the creation of ZF-based genomic medicines.
Our investment in world-class manufacturing capabilities gives us the advantage of greater control over timelines, quality and supply for our robust pipeline.
We have a state-of-the-art cGMP AAV manufacturing facility and trusted CDMO partner that together will support Sangamo’s diverse pipeline now, and in the future.